Inventor · disambiguated record
Peter D. Senter
Also filed as: SENTER PETER · SENTER PETER D
53 granted patents·35 pending applications·6,850 citations·filing 1984–2024
99Inventor score
Files withSEATTLE GENETICS INC31SEAGEN INC13DORONINA SVETLANA O12BRISTOL MYERS CO5DANA FARBER CANCER INST INC5
Top patents by PatentIndex Score
88 records- 0199US10808039B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2019·Granted Oct 20, 2020·18 cites·10 claims
- 0299US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0399US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0499US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0599US7851437B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Dec 14, 2010·163 cites·42 claims
- 0699US7829531B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Nov 9, 2010·199 cites·81 claims
- 0799US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 0899US7659241B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2003·Granted Feb 9, 2010·442 cites·78 claims
- 0999US7553816B2p-amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2002·Granted Jun 30, 2009·178 cites·51 claims
- 1099US7498298B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·1.1k cites·22 claims
- 1199US7091186B2p-Amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2001·Granted Aug 15, 2006·211 cites·38 claims
- 1299US6884869B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2001·Granted Apr 26, 2005·562 cites·2 claims
- 1399US4569789AAcid-cleavable compound, use in protein conjugates and drug delivery systemsDANA FARBER CANCER INST INC·Filed 1985·Granted Feb 11, 1986·458 cites·17 claims
- 1499US4542225AAcid-cleavable compoundDANA FARBER CANCER INST INC·Filed 1984·Granted Sep 17, 1985·107 cites·20 claims
- 1598US8703714B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Apr 22, 2014·59 cites·48 claims
- 1698US8697688B2Pyrrolobenzodiazepines used to treat proliferative diseasesHOWARD PHILIP WILSON·Filed 2011·Granted Apr 15, 2014·155 cites·7 claims
- 1798US7098308B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2004·Granted Aug 29, 2006·101 cites·6 claims
- 1898US4975278AAntibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cellsBRISTOL MYERS CO·Filed 1988·Granted Dec 4, 1990·1k cites·64 claims
- 1998US4625014ACell-delivery agentDANA FARBER CANCER INST INC·Filed 1984·Granted Nov 25, 1986·255 cites·28 claims
- 2098US4618492AAcid-cleavable compoundDANA FARBER CANCER INST INC·Filed 1985·Granted Oct 21, 1986·98 cites·6 claims
- 2197US9242013B2Targeted pyrrolobenzodiazapine conjugatesHOWARD PHILIP WILSON·Filed 2011·Granted Jan 26, 2016·78 cites·41 claims
- 2297US8557780B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Oct 15, 2013·32 cites·15 claims
- 2397US7423116B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2006·Granted Sep 9, 2008·51 cites·24 claims
- 2496US9592240B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Mar 14, 2017·23 cites·11 claims
- 2596US8609105B2Auristatin drug linker conjugatesSENTER PETER·Filed 2009·Granted Dec 17, 2013·92 cites·46 claims
- 2696US7256257B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2002·Granted Aug 14, 2007·69 cites·52 claims
- 2796US4952394ADrug-monoclonal antibody conjugatesBRISTOL MYERS CO·Filed 1987·Granted Aug 28, 1990·134 cites·6 claims
- 2895US11510959B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2021·Granted Nov 29, 2022·3 cites·11 claims
- 2995US10414826B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2017·Granted Sep 17, 2019·8 cites·20 claims
- 3095US5041424AEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS CO·Filed 1989·Granted Aug 20, 1991·68 cites·2 claims
- 3194US8309093B2Antibody drug conjugates (ADC) that bind to 24P4C12 proteinsGUDAS JEAN·Filed 2010·Granted Nov 13, 2012·19 cites·15 claims
- 3293US9463252B2Auristatin drug linker conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Oct 11, 2016·13 cites·43 claims
- 3393US8871720B2Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminusDORONINA SVETLANA O·Filed 2006·Granted Oct 28, 2014·29 cites·11 claims
- 3492US10933112B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2015·Granted Mar 2, 2021·5 cites·24 claims
- 3592US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 3691US8906376B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSENTER PETER D·Filed 2010·Granted Dec 9, 2014·13 cites·20 claims
- 3788US12036286B2Selective drug release from internalized conjugates of biologically active compoundsSEAGEN INC·Filed 2022·Granted Jul 16, 2024·2 cites·12 claims
- 3888US10561739B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Feb 18, 2020·4 cites·22 claims
- 3988US4904768AEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS CO·Filed 1988·Granted Feb 27, 1990·37 cites·31 claims
- 4087US9504702B2Methods of inhibition of protein fucosylation in vivo using fucose analogsSENTER PETER·Filed 2011·Granted Nov 29, 2016·9 cites·9 claims
- 4185US6492428B1Compounds having MIF antagonist activityPICOWER INST MED RES·Filed 2000·Granted Dec 10, 2002·23 cites·11 claims
- 4284US12257281B2Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2023·Granted Mar 25, 2025·0 cites·6 claims
- 4383US5773435AProdrugs for β-lactamase and uses thereofBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jun 30, 1998·71 cites·35 claims
- 4481US10342811B2Methods of inhibition of protein fucosylation in vivo using fucose analogsSEATTLE GENETICS INC·Filed 2016·Granted Jul 9, 2019·2 cites·20 claims
- 4580US6132722ARecombinant antibody-enzyme fusion proteinsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Oct 17, 2000·52 cites·8 claims
- 4679US9522194B2Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminusSEATTLE GENETICS INC·Filed 2014·Granted Dec 20, 2016·1 cites·12 claims
- 4778USRE35524EEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jun 3, 1997·27 cites·23 claims
- 4878US4888415AGelonin immunotoxinDANA FARBER CANCER INST INC·Filed 1988·Granted Dec 19, 1989·49 cites·10 claims
- 4978US2023132738A1Hydrophilic antibody-drug conjugatesSEAGEN INC·Filed 2022·Application pending·0 cites
- 5078US2020347149A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter D. Senter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →